Drug ID | DDPD09265 |
|
Drug Name | Lixisenatide | |
Molecular Weight | 4858.56 | |
Molecular Formula | C215H347N61O65S | |
CAS Number | 320367-13-3 | |
SMILES | CC[C@H](C)[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](N)CC1=CNC=N1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O | |
External Links | ||
DRUGBANK | DB09265 | |
PubChem Compound | 131704317 | |
PDR | 23928 |
Not Available
Property Name | Property Value | Unit | Raw Value | Raw Unit | Annotation | Reference |
---|---|---|---|---|---|---|
T Max | 2.3 | h | 1-3.5 | h | subcutaneous injection, SC; | DRUGBANK |
Clearance | 35.0 | L/h | 35.0 | L/h | DRUGBANK | |
Volume of Distribution | 100.0 | L | 100.0 | L | DRUGBANK | |
Half-life | 3.0 | h | 3 | h | DRUGBANK | |
Protein Binding | 55.0 | % | 55 | % | plasma proteins; | DRUGBANK |
Property Name | Property Value | Unit | Raw Value | Raw Unit | Annotation | Brand Name | Component | Reference |
---|---|---|---|---|---|---|---|---|
Max dose for adults | 0.02 | mg/day | 20 | mcg/day | subcutaneous injection, SC | Adlyxin | lixisenatide | PDR |
Max dose for geriatric | 0.02 | mg/day | 20 | mcg/day | subcutaneous injection, SC | Adlyxin | lixisenatide | PDR |